Answer
Aug 08, 2025 - 10:14 AM
Evolocumab, a PCSK9 inhibitor, can significantly lower LDL cholesterol levels. Clinical studies have shown that it can reduce LDL cholesterol by approximately 50-60% when used in combination with statins or other lipid-lowering therapies. The exact reduction can vary depending on the individual and their specific treatment regimen.
